Major study tracks 2500 liver cancer patients on new drugs
NCT ID NCT07233759
Summary
This study is looking back at how well newer drug treatments work for people with liver cancer. Researchers are reviewing the medical records of 2500 patients who received treatments like Keytruda, Tecentriq, and Lenvatinib between 2019 and 2024. The goal is to understand if these newer options help patients live longer or keep the cancer from growing compared to older standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
Conditions
Explore the condition pages connected to this study.